The Current Ratio as of December 2025 (TTM) for Excelsior Biopharma Inc. (6496.TWO) is 3.40

According to Excelsior Biopharma Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.40. This represents a change of -9.36% compared to the average of 3.75 of the last 4 quarters.

Excelsior Biopharma Inc. (6496.TWO) Historical Current Ratio (quarterly & annually)

How has 6496.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Excelsior Biopharma Inc. over the last ten years is 4.19. The current 3.40 Current Ratio has changed 8.01% with respect to the historical average. Over the past ten years (40 quarters), 6496.TWO's Current Ratio was at its highest in in the December 2023 quarter at 5.92. The Current Ratio was at its lowest in in the December 2022 quarter at 0.

Excelsior Biopharma Inc. (6496.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Excelsior Biopharma Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Excelsior Biopharma Inc. (6496.TWO) Average Current Ratio

How has 6496.TWO Current Ratio performed in the past?

The current Current Ratio of Excelsior Biopharma Inc. (6496.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Excelsior Biopharma Inc. (6496.TWO) Current Ratio vs. Peers

How is 6496.TWO’s Current Ratio compared to its peers?

Excelsior Biopharma Inc.’s Current Ratio is greater than Anxo Pharmaceutical Co., Ltd. (1.68), greater than Kim Forest Enterprise Co., Ltd. (1.61), less than Holy Stone Healthcare Co., Ltd. (7.56), greater than GeneReach Biotechnology Corp. (2.23), greater than Unicon Optical Co., Ltd. (2.15), greater than DV Biomed Co., Ltd. (3.36), less than MegaPro Biomedical Co., Ltd (4.34), greater than Tien Liang BioTech Co., Ltd. (0.51), greater than Prince Pharmaceutical Co., Ltd. (1.63), less than Great Novel Therapeutics Biotech & Medicals (30.32),

Build a custom stock screener for Excelsior Biopharma Inc. (6496.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Excelsior Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Excelsior Biopharma Inc. (6496.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Excelsior Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.